Literature DB >> 22673181

Immunohistochemical profile of NF-κB/p50, NF-κB/p65, MMP-9, MMP-2, and u-PA in experimental cervical spondylotic myelopathy.

Spyridon K Karadimas1, George Klironomos, Dionysios J Papachristou, Sofia Papanikolaou, Eleni Papadaki, George Gatzounis.   

Abstract

STUDY
DESIGN: The immunohistochemical profile of nuclear factor-κ B (NF-κB)/p50, NF-κB/p65, matrix metalloproteinase (MMP)-9, MMP-2, and urokinase-type plasminogen activator (u-PA) proteins was examined in spinal cord tissues coming from rabbits, which underwent chronic cervical spinal cord compression.
OBJECTIVE: To study the potential role of NF-κB and extracellular matrix proteins under the chronic mechanical compression of the cervical spinal cord. SUMMARY OF BACKGROUND DATA: Cervical spondylotic myelopathy (CSM) is the most common cause of spinal cord dysfunction among adults older than 55 years. Neuronal loss, myelin destruction, axonal degeneration, and glial scar formation are the principal neuropathological features of CSM. However, the biologic pathways that lead to these features remain unclear.
METHODS: In this study, we used a new animal experimental model of CSM developed in our laboratory. Briefly, after posterior cervical laminectomy, gradual and progressive compression (during 20 weeks) was achieved by introducing a piece of aromatic polyether (0.07 mm thick) under the C6 lamina in 15 New Zealand rabbits. In control animals (n = 15), the aromatic polyether was implanted and then removed after 60 seconds (sham operation). The immunoreactivity of p50 and p65 subunits of NF-kB, as well as that of MMP-2, MMP-9, and u-PA, was evaluated in paraffin-embedded spinal cord sections coming from both groups. The evaluation was performed using immunohistochemistry technique and the results were analyzed using SPSS for Windows, release 12.0 (SPSS Inc., Chicago, IL).
RESULTS: Increased immunoreactivity of both NF-κB subunits, p50 and p65, as well as MMP-2, MMP-9, and u-PA was demonstrated in animals with CSM in comparison with controls. Statistical analysis of the results revealed strong positive correlation between NF-κB subunits immunoreactivity and that of MMP-9, MMP-2, and u-PA.
CONCLUSION: There is a strong correlation between the immunoexpression of NF-κB/p50, NF-κB/p65, MMP-2, MMP-9, u-PA, and CSM.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22673181     DOI: 10.1097/BRS.0b013e318261ea6f

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  11 in total

1.  Role of MK2 signaling pathway in the chronic compression of cervical spinal cord.

Authors:  Hongxing Song; Xiutong Fang; Mingjie Wen; Fang Yu; Kai Gao; Chenli Sun; Zhenwei Wang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

2.  Alteration in chondroitin sulfate proteoglycan expression at the epicenter of spinal cord is associated with the loss of behavioral function in Tiptoe walking Yoshimura mice.

Authors:  Jun Wang; Xiaofang Wang; Wei Rong; Jia Lv; Feng Wei; Zhongjun Liu
Journal:  Neurochem Res       Date:  2014-10-02       Impact factor: 3.996

Review 3.  Cervical radicular pain: the role of interlaminar and transforaminal epidural injections.

Authors:  Laxmaiah Manchikanti; Frank J E Falco; Sudhir Diwan; Joshua A Hirsch; Howard S Smith
Journal:  Curr Pain Headache Rep       Date:  2014-01

Review 4.  Degenerative cervical myelopathy - update and future directions.

Authors:  Jetan H Badhiwala; Christopher S Ahuja; Muhammad A Akbar; Christopher D Witiw; Farshad Nassiri; Julio C Furlan; Armin Curt; Jefferson R Wilson; Michael G Fehlings
Journal:  Nat Rev Neurol       Date:  2020-01-23       Impact factor: 42.937

Review 5.  Pathobiology of cervical spondylotic myelopathy.

Authors:  Spyridon K Karadimas; Georgios Gatzounis; Michael G Fehlings
Journal:  Eur Spine J       Date:  2014-03-14       Impact factor: 3.134

6.  The Restless Spinal Cord in Degenerative Cervical Myelopathy.

Authors:  M Hupp; N Pfender; K Vallotton; J Rosner; S Friedl; C M Zipser; R Sutter; M Klarhöfer; J M Spirig; M Betz; M Schubert; P Freund; M Farshad; A Curt
Journal:  AJNR Am J Neuroradiol       Date:  2021-02-04       Impact factor: 3.825

7.  Role of cantharidin in the activation of IKKα/IκBα/NF‑κB pathway by inhibiting PP2A activity in cholangiocarcinoma cell lines.

Authors:  Huijiang Zhou; Jiangfeng Xu; Shuai Wang; Jinfeng Peng
Journal:  Mol Med Rep       Date:  2018-04-05       Impact factor: 2.952

8.  Clinical outcomes of epidural and intradural decompression for treatment of degenerative cervical myelopathy.

Authors:  Genlong Jiao; Zhizhong Li; Pan Zhou; Jinpei Yang; Xueshi Li
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

9.  Degenerative Cervical Myelopathy; A Review of the Latest Advances and Future Directions in Management.

Authors:  Jamie R F Wilson; Jetan H Badhiwala; Ali Moghaddamjou; Allan R Martin; Michael G Fehlings
Journal:  Neurospine       Date:  2019-08-26

10.  The Pathophysiology of Degenerative Cervical Myelopathy and the Physiology of Recovery Following Decompression.

Authors:  Farhana Akter; Xinming Yu; Xingping Qin; Shun Yao; Parisa Nikrouz; Yasir Syed; Mark Kotter
Journal:  Front Neurosci       Date:  2020-04-30       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.